These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


234 related items for PubMed ID: 15586571

  • 1. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog.
    Preziosi R, Morini M, Sarli G.
    J Vet Diagn Invest; 2004 Nov; 16(6):554-61. PubMed ID: 15586571
    [Abstract] [Full Text] [Related]

  • 2. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
    Kiupel M, Webster JD, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V.
    Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
    [Abstract] [Full Text] [Related]

  • 3. Canine mast cell tumors express stem cell factor receptor.
    Reguera MJ, Rabanal RM, Puigdemont A, Ferrer L.
    Am J Dermatopathol; 2000 Feb; 22(1):49-54. PubMed ID: 10698217
    [Abstract] [Full Text] [Related]

  • 4. HSP32 and HSP90 Immunoexpression, in Relation to Kit Pattern, Grading, and Mitotic Count in Canine Cutaneous Mast Cell Tumors.
    Romanucci M, Massimini M, Ciccarelli A, Malatesta D, Bongiovanni L, Gasbarre A, Della Salda L.
    Vet Pathol; 2017 Mar; 54(2):222-225. PubMed ID: 27627984
    [Abstract] [Full Text] [Related]

  • 5. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M, Giantin M, Capello K, Carminato A, Morello EM, Vercelli A, Granato A, Buracco P, Dacasto M, Mutinelli F.
    Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunohistochemical characterization of feline mast cell tumors.
    Mallett CL, Northrup NC, Saba CF, Rodriguez CO, Rassnick KM, Gieger TL, Childress MO, Howerth EW.
    Vet Pathol; 2013 Jan; 50(1):106-9. PubMed ID: 22492208
    [Abstract] [Full Text] [Related]

  • 8. Receptor Tyrosine Kinase Expression Profiles in Canine Cutaneous and Subcutaneous Mast Cell Tumors.
    Thompson JJ, Morrison JA, Pearl DL, Boston SE, Wood GA, Foster RA, Coomber BL.
    Vet Pathol; 2016 May; 53(3):545-58. PubMed ID: 26459517
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine.
    Thamm DH, Weishaar KM, Charles JB, Ehrhart EJ.
    Vet Comp Oncol; 2020 Jun; 18(2):169-175. PubMed ID: 31365175
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
    Sabattini S, Bettini G.
    Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
    [Abstract] [Full Text] [Related]

  • 15. Expression of KIT receptor in feline cutaneous mast cell tumors.
    Rodriguez-Cariño C, Fondevila D, Segalés J, Rabanal RM.
    Vet Pathol; 2009 Sep; 46(5):878-83. PubMed ID: 19429979
    [Abstract] [Full Text] [Related]

  • 16. Morphometry of canine cutaneous mast cell tumors.
    Strefezzi Rde F, Xavier JG, Catão-Dias JL.
    Vet Pathol; 2003 May; 40(3):268-75. PubMed ID: 12724567
    [Abstract] [Full Text] [Related]

  • 17. Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome.
    Camus MS, Priest HL, Koehler JW, Driskell EA, Rakich PM, Ilha MR, Krimer PM.
    Vet Pathol; 2016 Nov; 53(6):1117-1123. PubMed ID: 27034386
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.